Skip Navigation


Journal of Intellectual Property Law & Practice Advance Access originally published online on November 3, 2006
Journal of Intellectual Property Law & Practice 2006 1(13):819-821; doi:10.1093/jiplp/jpl185
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/13/819    most recent
jpl185v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Albainy-Jenei, S.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors (2006). Published by Oxford University Press. All rights reserved.

Current Intelligence

Claim construction and the doctrine of equivalents in Amgen v Transkaryotic Therapies, Inc

Stephen Albainy-Jenei
Frost Brown Todd LLC US Attorney-at-Law Cincinnati, OH

The US Court of Appeals for the Federal Circuit has affirmed a District Court decision that Transkaryotic Therapies Inc and Aventis Pharmaceuticals Inc infringed Amgen's erythropoietin (EPO) patents; this decision upheld the validity of two of Amgen's EPO patents and the infringement by Transkaryotic of three patents, including a patent that does not expire until 2015.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.